Simultaneous targeting of EGFR and ALK in EML4-ALK positive lung cancer to inhibit tumor cell proliferation and migration

被引：1
|
作者：
Li, Chunrong
Kern, Joseph G.
Huang, Shyhmin
Armstrong, Eric A.
Werner, Lauryn R.
Harari, Paul M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2102A
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2102A
引用
收藏
页数：3
相关论文
共 50 条
  • [1] EML4-ALK Fusion in Lung
    Mano, Hiroyuki
    Takeuchi, Kengo
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1552 - 1553
  • [2] EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer
    de Mello, Ramon Andrade
    Liu, Davi J. J.
    Aguiar, Pedro N., Jr.
    Tadokoro, Hakaru
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2016, 11 (04) : 393 - 400
  • [3] EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
    Choi, Young Lim
    Soda, Manabu
    Yamashita, Yoshihiro
    Ueno, Toshihide
    Takashima, Junpei
    Nakajima, Takahiro
    Yatabe, Yasushi
    Takeuchi, Kengo
    Hamada, Toru
    Haruta, Hidenori
    Ishikawa, Yuichi
    Kimura, Hideki
    Mitsudomi, Tetsuya
    Tanio, Yoshiro
    Mano, Hiroyuki
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18): : 1734 - 1739
  • [4] Codrug Approach for the Potential Treatment of EML4-ALK Positive Lung Cancer
    Garces, Aimie E.
    Al-Hayali, Mohammed
    Lee, Jong Bong
    Li, Jiaxin
    Gershkovich, Pavel
    Bradshaw, Tracey D.
    Stocks, Michael J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (03): : 316 - 321
  • [5] Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)
    Moran, Teresa
    Quiroga, Vanesa
    Llanos Gil, Maria de Los
    Vila, Laia
    Pardo, Nuria
    Carcereny, Enric
    Capdevila, Laia
    Munoz-Marmol, Ana M.
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (02) : 128 - 141
  • [6] Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer
    Lin, Jessica J.
    Zhu, Viola W.
    Yoda, Satoshi
    Yeap, Beow Y.
    Schrock, Alexa B.
    Dagogo-Jack, Ibiayi
    Jessop, Nicholas A.
    Jiang, Ginger Y.
    Le, Long P.
    Gowen, Kyle
    Stephens, Philip J.
    Ross, Jeffrey S.
    Ali, Siraj M.
    Miller, Vincent A.
    Johnson, Melissa L.
    Lovly, Christine M.
    Hata, Aaron N.
    Gainor, Justin F.
    Iafrate, Anthony J.
    Shaw, Alice T.
    Ou, Sai-Hong Ignatius
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (12) : 1199 - +
  • [7] EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
    Koivunen, Jussi P.
    Mermel, Craig
    Zejnullahu, Kreshnik
    Murphy, Carly
    Lifshits, Eugene
    Holmes, Alison J.
    Choi, Hwan Geun
    Kim, Jhingook
    Chiang, Derek
    Thomas, Roman
    Lee, Jinseon
    Richards, William G.
    Sugarbaker, David J.
    Ducko, Christopher
    Lindeman, Neal
    Marcoux, J. Paul
    Engelman, Jeffrey A.
    Gray, Nathanael S.
    Lee, Charles
    Meyerson, Matthew
    Janne, Pasi A.
    CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4275 - 4283
  • [8] EML4-ALK AND OTHER FUSION KINASES IN LUNG CANCER
    Mano, Hiroyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S438 - S438
  • [9] EML4-ALK Fusion in Lung Reply
    Falini, Brunangelo
    Martelli, Maria Paola
    Pileri, Stefano A.
    Sozzi, Gabriella
    Gasparini, Patrizia
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1553 - 1554
  • [10] Analysis of EML4-ALK fusion transcripts in plasma and platelets to monitor response to crizotinib in EML4-ALK positive non-small cell lung cancer patients (NSCLC)
    Aguado, Cristina
    Teixido, Cristina
    Gimenez-Capitan, Ana
    Gil, Maria de los Llanos
    Rodriguez, Sonia
    Viteri, Santiago
    Karachaliou, Niki
    Aldeguer, Erika
    Peg, Vicente
    Alonso, Lidia
    Molina-Vila, Miguel Angel
    Rosell, Rafael
    CANCER RESEARCH, 2017, 77
12345